83. Cliff Bleustein, CTG: $2.02M

Position: President and CEO

Other Compensation: $1.14M

Stock Award: $600,000

Salary: $279,000

Bleustein joined CTG as its president and CEO in April 2015. He resigned from CTG in July 2016 and was named AposTherapy's U.S. CEO in May 2017.

The fiscal year for CTG, No. 65 on the CRN SP 500, ended Dec. 31, with sales for the Buffalo, N.Y.-based company plunging 12.1 percent to $324.9 million and a recorded net loss of $34.6 million, down from net income of $6.5 million the year prior. CTG's stock fell 35.4 percent during the 2016 calendar year to $4.21 per share.

Other compensation for Bleustein included: a $1.1 million payment upon his resignation; $13,000 for a long-term disability plan, accidental death and dismemberment and travel accident plan, and medical and dental plan; and $5,000 in company contributions to his 401(k) retirement plan.